Cincinnati Children's Hospital Medical Center
Cincinnati, Ohio, 45229, United States
NCT Number: NCT03957993
This study aims to measure the impact of a telehealth-based model of occupational therapy (OT) treatment on clinical outcomes for children with autism spectrum disorder (ASD) and/or attention deficit hyperactivity disorder (ADHD). Half of the participants will receive clinic-based, in-person services and half of the participants will receive video-based, Telehealth services.
Looking for future studies?
Notify Me4 year–18 year
All sexes
Interventional
Not applicable
Cincinnati, Ohio, 45229, United States
Children with autism spectrum disorder (ASD) and/or attention deficit hyperactivity disorder (ADHD) often receive occupational therapy (OT), which traditionally takes place in a clinical setting. This setting may present barriers and distractors that make it hard for children to achieve their OT goals. Telehealth-based sessions provide an alternative, allowing the therapist to be virtually present within the home.Once enrolled, children will randomly be assigned to be in one of two groups: (1) Standard, in which children will receive clinic-based services as per standard of care OR (2) Telehealth, in which children will receive in-home services on a video-based platform on a timeline identical to what they would receive if they were in the Standard group. Children in both groups will participate for the duration of the episode of care, estimated to last 10-12 weeks. Assessments will be completed at initial evaluation, discharge, and three months following discharge.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The caregiver will be with the participant in their home environment receiving occupational therapy via Telehealth (video-calling) with the occupational therapist.
The caregiver and participant will be in the clinic receiving occupational therapy in-person with the occupational therapist.
Time frame: Baseline and approximately 2 weeks after treatment (approximately 14 weeks after baseline measurement)
The Goal Attainment Scale is a criterion-referenced, individualized outcome measure used to assess progress on goals that are important to the child and their family. The Goal Attainment Scale is reliable, valid and responsive to change. The status of goal attainment is rated on a scale of +2 to -2 (+2 is much more than expected, -2 is much less than expected)
Time frame: Baseline and approximately 2 weeks after treatment (approximately 14 weeks after baseline measurement)
The Canadian Occupational Performance Measure is a valid, reliable, and sensitive assessment tool that measures the caregiver/patient's perception of the participant's performance and satisfaction on goals that are important to the child and his/her caregiver. The performance and satisfaction are rated on a scale from 1-10 (1 is low performance/satisfaction, 10 is high performance/satisfaction).
Children's Hospital Medical Center, Cincinnati
Other
Pilot Study: Addressing Home-Based Functional Challenges Via Telehealth-Based Occupational Therapy
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05803252
Attention Deficit Disorder with Hyperactivity, Attention Deficit Hyperactivity Disorder
Hong Kong
View Trial DetailsNCT06262646
Attention Deficit Disorder with Hyperactivity, Attention Deficit Hyperactivity Disorder
Hong Kong
View Trial DetailsNCT04769011
Attention Deficit Disorder with Hyperactivity, Attention Deficit Hyperactivity Disorder
Bosisio Parini, Lecco, Italy
View Trial DetailsNCT03337646
Attention Deficit Disorder with Hyperactivity, Attention Deficit Hyperactivity Disorder
Ottawa, Ontario, Canada
View Trial Details